Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico멕시코 누에보레온의 무증상 성인에서 SARS-COV-2 바이러스에 의해 유도된 IgG 항체의 유병률Article Published on 2021-10-012022-09-11 Journal: Journal of medical virology [Category] MERS, SARS, 진단, 치료법, [키워드] 95% CI 95% confidence interval Adults age analyzed Asymptomatic asymptomatic individual Asymptomatic individuals carried coronavirus COVID-19 COVID-19 vaccine cross-sectional cross-sectional study Diagnosis distribution eligible Evidence evidence of Geographic distribution highest house IgG IgG antibodies IgG antibody Immunoglobulin Immunoglobulin G individual Latin America MOST no difference no differences nucleocapsid protein Prevalence preventive measure preventive measures previous diagnosis promotion Protein reported SARS-COV-2 infection SARS-CoV-2 nucleocapsid SARS-CoV2 screened Seroprevalence Sex Symptom virus was done Week [DOI] 10.1002/jmv.27131 PMC 바로가기 [Article Type] Article
Presence of SARS-CoV-2 Viral RNA in Aqueous Humor of Asymptomatic Individuals무증상 개인의 수성 유머에서 SARS-CoV-2 바이러스 RNA의 존재Article Published on 2021-10-012022-09-11 Journal: American journal of ophthalmology [Category] SARS, 치료기술, [키워드] absence acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 All participants analyzed anterior segment aqueous Aqueous humor ASC asymptomatic individual Asymptomatic individuals Blood-ocular barrier Chain Reaction coronavirus cross-sectional cross-sectional study demographic demonstrated detectable determine Enrollment humor Inconclusive individual information nasal swab negative sample ophthalmic outcome participant Participants Patient polymerase chain polymerase chain reaction Presence presenting proceed Prospective raise real-time reverse transcriptase Real-time reverse transcriptase polymerase chain reaction reported symptom required reverse transcriptase Reverse transcriptase polymerase chain reaction Ribonucleic acid RNA SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 viral SARS-CoV-2 viral RNA Secondary analyses setting severe acute respiratory syndrome Coronavirus South study period surgery surgical Symptoms symptoms prior Viral RNA virus were excluded [DOI] 10.1016/j.ajo.2021.05.008 PMC 바로가기 [Article Type] Article
An assessment of case-fatality and infection-fatality rates of first and second COVID-19 waves in Italy이탈리아의 1차 및 2차 COVID-19의 사례 치사율 및 감염 치사율 평가Article Published on 2021-10-012022-09-11 Journal: Acta bio-medica : Atenei Parmensis [Category] SARS, 변종, [키워드] affected anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody asymptomatic individual Asymptomatic individuals available data collected country COVID-19 COVID-19 case COVID-19 severity defined European Fatality rate First wave Infection Influenza investigated Italy measure median value methodological more difficult pandemic SARS-COV-2 infection SARS-CoV-2 testing second wave Spread tested the SARS-CoV-2 vaccine availability variant [DOI] 10.23750/abm.v92iS6.12241 PMC 바로가기 [Article Type] Article
Rapid Screening of COVID-19 Directly from Clinical Nasopharyngeal Swabs Using the MasSpec PenMasSpec 펜을 사용하여 임상 비인두 면봉에서 직접 COVID-19의 신속한 스크리닝Article Published on 2021-09-212022-09-11 Journal: Analytical Chemistry [Category] SARS, 치료기술, [키워드] Accuracy Analysis analyzed Asymptomatic Asymptomatic individuals Chain Reaction Classifier clinical COVID-19 COVID-19 disease diagnostic test diagnostic tests electrospray ionization ESI gold gold standard individual individuals information ionization mass spectrometry minute moderate to severe Nasopharyngeal swab nasopharyngeal swabs outbreak patients with moderate PCR PCR-negative PCR-positive PCR-positive patient Pen polymerase chain polymerase chain reaction positive profile profiles Rapid reagents representing SARS-COV-2 infection Screening sensitivity severe symptom specificity statistical Swab symptomatic symptomatic COVID-19 this system while yielding [DOI] 10.1021/acs.analchem.1c01937 PMC 바로가기 [Article Type] Article
Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19사설: 1형 인터페론을 포함한 면역 체계의 구성 요소에 대한 자가항체 및 심각한 COVID-19의 위험Editorial Published on 2021-09-202022-09-11 Journal: Medical science monitor : international medical jo [Category] SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Asymptomatic individuals autoantibodies autoantibody chemokines Clinical outcome clinical outcomes clinical risk Clinical studies clinical study complement complement components component components coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Cytokines editorial identify IFNs immune system Including Infection interferons marker Patient patients with SARS-CoV-2 predict recent finding respiratory risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe COVID-19 symptomatic System type 1 interferon type 1 interferons [DOI] 10.12659/MSM.934766 PMC 바로가기 [Article Type] Editorial
Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals무증상 SARS-CoV-2 감염자의 장기간 상승된 염증성 단백질 수치Immunology Published on 2021-09-172022-09-11 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료법, [키워드] activated activated macrophages Alpha antibodies antibody Asymptomatic asymptomatic individual Asymptomatic individuals CD137 CD4 CD69 clinical feature Clinical features clinical monitoring complications controls correlated declined domain Evidence First wave IL18 immune response immune responses individual individuals Infection infections Inflammation inflammation markers inflammatory effect Level life-threatening marker Monocytes N protein no decrease OSM persistence positive individuals Post-infection Protein S-RBD S100A12 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid seronegative Seropositivity Serum level serum levels severe disease spike spike receptor-binding domain Spread Support T cell T cell response T cell responses the antibody understanding upregulation Viral viral infection viral neutralization [DOI] 10.3389/fimmu.2021.709759 PMC 바로가기 [Article Type] Immunology
Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 20212021년 6월부터 7월까지 프랑스, 지역 사회에서 SARS-CoV-2 Delta 및 Alpha 변이체 및 숙주 내 바이러스 부하 역학의 백신 돌발 감염 특성화Rapid Communication Published on 2021-09-162022-09-10 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] 95% CI Alpha Alpha variant Asymptomatic individuals Breakthrough infection Community Cq value Cq values Delta delta variant effect size France PCR SARS-CoV-2 SARS-CoV-2-positive patient SARS-CoV-2-positive patients significantly higher symptom onset symptomatic individual symptomatic individuals Symptoms tested vaccinated individual vaccination vaccine breakthrough infection Viral load [DOI] 10.2807/1560-7917.ES.2021.26.37.2100824 PMC 바로가기 [Article Type] Rapid Communication
Asymptomatic COVID-19 Individuals Tend to Establish Relatively Balanced Innate and Adaptive Immune ResponsesArticle Published on 2021-08-302022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] acute phase age Asymptomatic Asymptomatic case asymptomatic individual Asymptomatic individuals asymptomatic infection avoidance Balanced Clinical characteristics Clinical data Clinical outcome Coagulation comprehensive analysis COVID-19 COVID-19 pandemic CRP decrease demographic characteristics effective feature fibrinogen immune Immune cell Immune phenotype immune response immune responses immunological characteristics increase in individual individual immune response Inflammatory responses Innate Laboratory Lymphocyte count marker MLR MNKR Monocytes NK cells NLR pathogenesis of COVID-19 pathogenic mechanism patients with SARS-CoV-2 performed Perspective potential risk predict proportion Protective Protein response Sample size sample sizes SARS-CoV-2 significantly higher symptomatic individual symptomatic individuals Th17 the disease Treg virus transmission [DOI] 10.3390/pathogens10091105 PMC 바로가기 [Article Type] Article
Mitigating COVID-19 outbreaks in workplaces and schools by hybrid telecommutingResearch Article Published on 2021-08-262022-10-28 Journal: PLoS Computational Biology [Category] COVID-19, MERS, SARS, [키워드] Analysis Asymptomatic individuals Complete Contact coronavirus country COVID-19 COVID-19 epidemic COVID-19 outbreak develop effective Effectiveness Epidemic epidemicity Epidemics epidemiological feature France Guidance help include index case Interaction Intervention investigated Local mitigate outbreak pre-symptomatic provide public health random Reproduction number risk Rotation SARS-CoV-2 School Schools Spread super-spreaders threshold Topology Transmission Transmission model virus spread [DOI] 10.1371/journal.pcbi.1009264 PMC 바로가기 [Article Type] Research Article
Lung Fibrosis after COVID-19: Treatment ProspectsReview Published on 2021-08-172022-10-28 Journal: Pharmaceuticals [Category] COVID-19, [키워드] antifibrotic therapy Asymptomatic individuals caused clinical trial Community Complication complications contagious infection COVID COVID-19 death deupirfenidone diffusing drug candidates effective therapy effort fibrosis fraction impairment incidence incidence rate interstitial lung lung damage Lung fibrosis Lung pathology moderate morbidity MOST Nintedanib Novel coronavirus pathogen Patient Pirfenidone progression pulmonary damage pulmonary fibrosis reduction in rehabilitation remained respiratory complication respiratory manifestation SARS patient SARS-CoV-2 the disease the patient These data treamid Treatment Vaccine Vascular [DOI] 10.3390/ph14080807 PMC 바로가기 [Article Type] Review